Abstract-Gut microbiota modulates metabolic and immunoregulatory axes and contributes to the pathophysiology of diseases with inflammatory components, such as atherosclerosis, diabetes mellitus, and ischemic stroke. Inflammation is emerging as a critical player in the pathophysiology of an intracranial aneurysm. Therefore, we hypothesized that the gut microbiota affects aneurysm formation by modulating inflammation. We induced intracranial aneurysms in mice by combining systemic hypertension and a single injection of elastase into the cerebrospinal fluid. Depletion of the gut microbiota was achieved via an oral antibiotic cocktail of vancomycin, metronidazole, ampicillin, and neomycin. Antibiotics were given 3 weeks before aneurysm induction and either continued until the end of the experiment or stopped 1 day before aneurysm induction. We also assessed the effects of the gut microbiota depletion on macrophage infiltration and mRNA levels of inflammatory cytokines. Gut microbiota depletion by antibiotics reduced the incidence when antibiotics were started 3 weeks before aneurysm induction and continued until the end of the experiment (83% versus 6%, P<0.001). Even when antibiotics were stopped 1 day before aneurysm induction, the gut microbiota depletion significantly reduced the incidence of aneurysms (86% versus 28%, P<0.05). Both macrophage infiltration and mRNA levels of inflammatory cytokines were reduced with gut microbiota depletion. These findings suggest that the gut microbiota contributes to the pathophysiology of aneurysms by modulating inflammation. Human studies are needed to determine the exact contribution of the gut microbiota to the pathophysiology of aneurysm formation and disease course in humans. (Hypertension. 2019;73:491-496.
G ut microbiota is emerging as a critical environmental factor that contributes to human physiology and pathology. [1] [2] [3] [4] Recent studies suggest that gut microbiota affects various diseases in which inflammation plays pivotal roles in determining the course and severity of the disease. [4] [5] [6] [7] [8] Animal studies suggest that the gut microbiota influences the progression and outcomes of atherosclerotic disease, diabetes mellitus, and ischemic stroke, disease processes that involve inflammation. 2, [9] [10] [11] [12] [13] Gut microbiota may affect the disease courses through the modulation of metabolic and immunoregulatory axes. 5, 14, 15 Various environmental factors, including diet, lifestyle, physical activity, sanitation, alcohol, and smoking, determine the composition of the gut microbiota. 3, [16] [17] [18] [19] Among those many environmental factors, diet is considered the most significant in determining the diversity and composition of the human gut microbiota. 16, 17, 20, 21 Clinical and animal studies suggest critical roles of inflammation and inflammatory cells in the pathophysiology of intracranial aneurysms. [22] [23] [24] [25] [26] By modulating vascular inflammation, the gut microbiota may affect the disease course of intracranial aneurysms. As a first step to study the potential contribution of the gut microbiota to the pathophysiology of intracranial aneurysms, we tested whether the presence of the gut microbiota affects the formation of intracranial aneurysms in mice. We used a well-established method of antibioticsinduced depletion of the mice gut microbiota.
6,27

Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. Experiments were conducted in accordance with the guidelines approved by the Institutional Animal Care and Use Committee. We used 10-to 12-week-old C57BL/6J mice (Jackson Laboratory, Bar Harbor, Maine). Intracranial aneurysms were induced by combining induced
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February 2019 systemic hypertension and a single injection of elastase (35 milliunits; mU) into the cerebrospinal fluid at the right basal cistern as we previously described. 23, 24, 28, 29 Detailed methods are described in the online-only Data Supplement.
Two blinded observers performed a daily neurological examination. 24 Neurological symptoms were scored as follows: 0, normal function; 1, reduced eating or drinking activity demonstrated by a weight loss >2 g of body weight (10% weight loss) >24 hours; 2, flexion of the torso and forelimbs on lifting the whole animal by the tail; 3, circling to 1 side with a normal posture at rest; 4, leaning to 1 side at rest; and 5, no spontaneous activity. Mice were euthanized 3 weeks after aneurysm induction or when they developed neurological symptoms associated with aneurysmal subarachnoid hemorrhage (score, 1-5). Two blinded observers assessed the formation of intracranial aneurysms by examining the Circle of Willis and its major branches under a dissecting microscope (×10). Intracranial aneurysms were defined as a localized outward bulging of the vascular wall in the Circle of Willis or its major primary branches, as previously described. 28 Representative aneurysms are shown in Figure 1 . We have observed slight dilation of cerebral arteries ipsilateral to the elastase injection, consistent with our previous studies. 23, 28, 30 
Depletion of the Gut Microbiota
To deplete the gut microbiota, an antibiotic cocktail composing vancomycin (0.5 g/L), metronidazole (1 g/L), ampicillin (1 g/L; SigmaAldrich Inc), and neomycin (1 g/L) (Life Technologies Corporation) was administered through drinking water. 6, 31, 32 This method has been shown to effectively abolish the intestinal flora in mice. 6, 32 In the first experiment, the antibiotic cocktail or vehicle was started 3 weeks before aneurysm induction and continued until the end of the experiment. In the second experiment, the antibiotic cocktail or vehicle was started 3 weeks before aneurysm induction and stopped 1 day before aneurysm induction. Fecal samples were tested for aerobic and anaerobic fecal cultures (Charles River Laboratories, Wilmington, MA) every day. In addition, fecal samples were cultured on LB (Luria Broth) agar plate for the rapid detection of bacteria daily. The antibiotic-treated mice whose fecal culture showed a presence of the fecal bacteria before or after aneurysmal induction were excluded from this study.
Histology
For quantification of macrophages infiltration into cerebral arteries, additional 8 to 10 mice in each group were euthanized 4 days after the induction of aneurysms. From each mouse, 1 cross-sectional slice of the middle cerebral artery, immediately distal to the bifurcation from the internal carotid artery, was used for staining with antimouse CD68 to detect macrophages. 23 Macrophage infiltration was assessed by counting the number of the positive cells per unit of area (0.01 square of millimeter) as previously described. 33 From 15 to 20 sections of cerebral arteries, a blinded observer randomly chosen 2 sections. Then, 2 blinded investigators counted macrophages independently. Average values of measurements from 2 blinded observers were used for the final analysis.
Real-Time Polymerase Chain Reaction Analysis
In separate sets of animals, we collected the total RNA samples from cerebral arteries (Circle of Willis including aneurysms) at 14 days after aneurysm induction. We measured mRNA expression levels of inflammation-related cytokines (MCP-1 [monocyte chemoattractant
, and TNF-α [tumor necrosis factor-α]). The whole cerebral arteries, including aneurysms, were isolated, and total RNA was extracted using the RNeasy Mini Kit (Qiagen, CA). The total RNAs were transcribed to cDNA using QuantiTect reverse transcription kit (Qiagen). The mRNA expression levels were determined using SYBR Green technology (Applied Biosystems, CA). Quantitative values were obtained from the threshold cycle value (Ct), and the data were analyzed by the 2 −
◿◿
CT method. The transcript amount of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was quantified as an internal RNA control.
Statistical Analysis
For the primary outcome (incidence of aneurysms), we used the Fisher exact test. As an exploratory analysis, the survival analysis was performed using the log-rank test. Mice that did not develop aneurysms were excluded from the survival analysis. For systolic blood pressure, cell counts, and mRNA expression, the Wilcoxon signedrank test was used. A P<0.05 were considered statistically significant. Data are expressed as means±SD.
Results
Depletion of Gut Microbiota by Antibiotics Treatment Reduced the Formation of Intracranial Aneurysms
As a first step, we assessed the effects of the gut microbiota depletion on the formation of aneurysms. The antibiotic cocktail or vehicle was started 3 weeks before aneurysm induction and continued until 3 weeks after aneurysm induction (Figure 2A) as previously described. 6, 32, 34 As shown in Figure 2B , the depletion of the gut microbiota significantly reduced the incidence of aneurysms (gut microbiota-depleted versus intact gut microbiota: 6% versus 83%, P<0.001). In the intact gut microbiota group, 17 of 19 aneurysms presented as ruptured aneurysms. In the gut microbiota-depleted group, there was no ruptured aneurysm. For the purpose of exploratory analysis, a symptom-free curve (Kaplan-Meier analysis curve) was plotted after excluding mice that did not have aneurysms.
A log-rank test revealed the higher symptom-free rate in the antibiotics-treated group compared with the vehicle-treated group ( Figure 2C ; 6% versus 76% at 21 days, P<0.001). There was no difference in systolic blood pressure between gut microbiota-depleted mice and control mice ( Figure 2D ).
Depletion of Gut Microbiota by Antibiotics Reduced Aneurysm Formations Even When the Antibiotics Treatment Was Stopped Before the Induction of Aneurysms
As a next step, to exclude the possibility of direct effects of antibiotics on aneurysm formation, we started the antibiotics cocktail 3 weeks before aneurysm induction and stopped it 1 day before aneurysm induction ( Figure 2E ). Those mice that developed positive fecal culture during the experimental period were excluded from the analysis. As shown in Figure 2F , even when the antibiotics treatment was stopped 1 day before aneurysm induction, the depletion of the gut microbiota resulted in reduced aneurysm formation (gut microbiota-depleted versus intact gut microbiota: 28% versus 86%, P<0.05). Figure 3A shows representative aneurysms from the gut microbiota-depleted group and the intact gut microbiota group. Hematoxylin-eosin staining revealed the disruption of elastic lamina in both groups, which is a typical histological finding in human intracranial aneurysms. 35, 36 Because both clinical and experimental studies strongly indicated the key roles of macrophages and inflammation in the intracranial aneurysm formation and growth, 23, 26, 37, 38 we assessed macrophage infiltration in aneurysms. Figure 2 . Depletion of gut microbiota by antibiotics treatment reduced the formation of intracranial aneurysms. A, Experimental protocol 1. Gut microbiota was depleted by the oral antibiotics treatment that was started 3 weeks before aneurysm induction and continued for 6 weeks. B, Incidence of aneurysms. Depletion of gut microbiota by antibiotics reduced the formation of aneurysms. C, Symptom-free curve (Kaplan-Meier analysis curve). Depletion of gut microbiota by antibiotics improved the symptom-free survival. D, Systolic blood pressure in the mice that induced DOCA (deoxycorticosterone acetate)-salt hypertension, and the mice that received antibiotics or vehicle. Antibiotics treatment did not affect blood pressure levels in our model. E, Experimental protocol 2. To exclude the possibility of direct effects of antibiotics on aneurysm formation, the antibiotics treatment was started 3 weeks before aneurysm induction and stopped 1 day before aneurysm induction. F, Even when the antibiotics treatment was stopped 1 day before aneurysm induction, the depletion of the gut microbiota resulted in reduced aneurysm formation.
Effects of the Depletion of Gut Microbiota on the Inflammation of Cerebral Arteries During Aneurysm Formation
In the intact gut microbiota group (vehicle group), macrophages (CD68-positive cells) were abundant in the aneurysmal walls but were scarce in the gut microbiota-depleted group ( Figure 3A) . The quantification of macrophages showed a reduced number of macrophages in the gut microbiota-depleted group compared with the number in intact gut microbiota group (4.0±2.3 versus 9.4±6.4/0.01 mm 2 , P<0.05; Figure 3B ).
We have also assessed mRNA expression of inflammatory cytokines that are mainly produced by macrophages using the real-time polymerase chain reaction ( Figure 3C ). We found that the depletion of the gut microbiota significantly reduced the mRNA levels of IL-1β, IL-6, and iNOS (all P<0.05). There was a trend for MCP-1 to be lower in the gut microbiota-depleted group than in the intact gut microbiota group (2.8 versus 1.1, P=0.06). There was no difference in TNF-α between the 2 groups (TNF-α: 1.5 versus 1.1; P=0.5).
Discussion
This proof-of-concept study strongly suggests contributions of the gut microbiota to the pathophysiology of intracranial aneurysms. Our findings showed that gut microbiota can affect the formation of intracranial aneurysms through the modulation of inflammation within the aneurysmal walls in mice. As the initial experiment, we abolished the entire gut microbiota as a simplistic method to test whether the presence or absence of the entire gut microbiota affects the formation of aneurysms. The experiment was not intended to test whether the gut microbiota has beneficial or harmful roles in the context of the pathophysiology of aneurysms. The depletion of the entire gut microbiota represents a highly artificial scenario. While some enteric bacteria may have beneficial roles, others may have harmful roles.
Our findings indicate that the gut microbiota affects the pathophysiology of intracranial aneurysm by modulation of the local inflammation. The transmigration of gut bacteria into the cerebral arteries may represent another potential mechanism. There are reports that suggest a potential link between odontogenic bacteria and the pathophysiology of intracranial aneurysms. 39, 40 In our study, however, we did not detect bacterial DNA in the cerebral arteries in our model; the migration of bacteria into the cerebral artery does not explain our findings. The manipulation of the gut microbiota may affect the induction of aneurysms by affecting blood pressure or the elastase activity in the cerebrospinal fluid. However, we did not detect any effects on blood pressure or the elastase activity by the antibiotic treatment.
Environmental factors may play a highly significant role in the pathophysiology of intracranial aneurysms. [41] [42] [43] A large twin study that analyzed ≈80 000 twin pairs revealed that the contribution of environmental factors to the development of aneurysmal rupture was far more important than the contribution of genetic factors. 44 The familial aggregation of aneurysmal subarachnoid rupture may be because of the familial aggregation of environmental factors. 41 The notion that environmental factors play far more important roles in the pathophysiology of intracranial aneurysms than genetic factors has been increasingly recognized. 41, 45 Mechanistically, the gut microbiota may directly affect the pathophysiology of intracranial aneurysms, but clinically, the gut microbiota profile may represent a biomarker that reveals collective effects of environmental factors. While animal studies may provide the proof-of-concept, comparative analysis of human gut microbiota from subjects with and without intracranial aneurysms would be needed to identify the exact contribution of gut microbiota to the pathophysiology of intracranial aneurysms, as the composition of gut microbiota may be fundamentally different between humans and laboratory animals.
There are several limitations of this study. First, our experiments relied on antibiotics treatment for the depletion of gut microbiota. And, we have tested feces only for cultivatable gut microbiota. An experimental approach using the gnotobiotic mice-mice that are raised in germ-free condition-may complement our approach. However, because of the surgical complexities of the mouse model of intracranial aneurysm, the use of gnotobiotic mice is highly challenging at this point. Second, we could not assess the potential roles of gut microbiota to the development of aneurysm rupture because the significant difference in the formation rate made it difficult to compare the rupture rate. Third, we did not assess the plasma levels of inflammatory mediators or the structural changes in the cerebral arteries in this study. Clearly, further studies are needed to identify the mechanisms by which the gut microbiota modulate the pathophysiology of intracranial aneurysms.
Our animal model may not completely replicate biological events that lead to intracranial aneurysm formation and growth in humans. However, our model recapitulates key features of human intracranial aneurysms, including the association between hypertension and the development of aneurysm rupture and sex dimorphism. 23, 24, 28, 46, 47 Another limitation of this study is that we used relatively young male mice to conduct the initial study. Ultimately, human studies are needed to further confirm the contribution of gut microbiota to the natural course of intracranial aneurysm.
Perspectives
This study showed a potential contribution of gut microbiota to the pathophysiology of intracranial aneurysm. As the roles of gut microbiota in human intracranial aneurysms would be undoubtedly complex and, perhaps, context-dependent, this study warrants future human studies to firmly establish the contribution of gut microbiota to the pathophysiology of intracranial aneurysms.
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